Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma

a Review

Waseem Lone, Aisha Alkhiniji, Jayadev Manikkam Umakanthan, Javeed Iqbal

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose of Review: Peripheral T cell lymphoma (PTCL) is a heterogeneous group of lymphoproliferative neoplasms, with at least 29 distinct entities described in current WHO classification. Using present diagnostic approaches, more than a third of PTCL cases cannot be classified, hence designated as PTCL-not otherwise specified (PTCL-NOS). Herein, we summarize the current genomic findings and their role in the molecular pathogenesis in different PTCL entities. Recent Findings: Gene expression profiling (GEP) studies have identified distinct molecular signatures for accurate diagnosis and elucidated oncogenic pathways enriched in major PTCL entities. Furthermore, genomic characterization has identified recurrent somatic mutations and potential therapeutic targets. Further efforts are underway to develop genetically faithful murine models. Summary: GEP studies have identified molecular subgroups of PTCL, characterized by distinct genetic and epigenetic alterations. Understanding the molecular mechanisms of T cell lymphomagenesis using in vivo model will help to reveal novel therapeutic targets.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalCurrent Hematologic Malignancy Reports
DOIs
StateAccepted/In press - Jun 27 2018

Fingerprint

Peripheral T-Cell Lymphoma
Gene Expression Profiling
Epigenomics
T-Lymphocytes
Mutation
Therapeutics
Neoplasms

Keywords

  • Anaplastic large cell lymphoma
  • Angioimmunoblastic T cell lymphoma
  • Gene expression profiling
  • Molecular signature
  • Peripheral T cell lymphoma-not otherwise specified
  • PTCL

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma : a Review. / Lone, Waseem; Alkhiniji, Aisha; Manikkam Umakanthan, Jayadev; Iqbal, Javeed.

In: Current Hematologic Malignancy Reports, 27.06.2018, p. 1-11.

Research output: Contribution to journalArticle

Lone, Waseem ; Alkhiniji, Aisha ; Manikkam Umakanthan, Jayadev ; Iqbal, Javeed. / Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma : a Review. In: Current Hematologic Malignancy Reports. 2018 ; pp. 1-11.
@article{431d1b3e563e4476945907b22e387208,
title = "Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review",
abstract = "Purpose of Review: Peripheral T cell lymphoma (PTCL) is a heterogeneous group of lymphoproliferative neoplasms, with at least 29 distinct entities described in current WHO classification. Using present diagnostic approaches, more than a third of PTCL cases cannot be classified, hence designated as PTCL-not otherwise specified (PTCL-NOS). Herein, we summarize the current genomic findings and their role in the molecular pathogenesis in different PTCL entities. Recent Findings: Gene expression profiling (GEP) studies have identified distinct molecular signatures for accurate diagnosis and elucidated oncogenic pathways enriched in major PTCL entities. Furthermore, genomic characterization has identified recurrent somatic mutations and potential therapeutic targets. Further efforts are underway to develop genetically faithful murine models. Summary: GEP studies have identified molecular subgroups of PTCL, characterized by distinct genetic and epigenetic alterations. Understanding the molecular mechanisms of T cell lymphomagenesis using in vivo model will help to reveal novel therapeutic targets.",
keywords = "Anaplastic large cell lymphoma, Angioimmunoblastic T cell lymphoma, Gene expression profiling, Molecular signature, Peripheral T cell lymphoma-not otherwise specified, PTCL",
author = "Waseem Lone and Aisha Alkhiniji and {Manikkam Umakanthan}, Jayadev and Javeed Iqbal",
year = "2018",
month = "6",
day = "27",
doi = "10.1007/s11899-018-0460-z",
language = "English (US)",
pages = "1--11",
journal = "Current Hematologic Malignancy Reports",
issn = "1558-8211",
publisher = "Springer Science + Business Media",

}

TY - JOUR

T1 - Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma

T2 - a Review

AU - Lone, Waseem

AU - Alkhiniji, Aisha

AU - Manikkam Umakanthan, Jayadev

AU - Iqbal, Javeed

PY - 2018/6/27

Y1 - 2018/6/27

N2 - Purpose of Review: Peripheral T cell lymphoma (PTCL) is a heterogeneous group of lymphoproliferative neoplasms, with at least 29 distinct entities described in current WHO classification. Using present diagnostic approaches, more than a third of PTCL cases cannot be classified, hence designated as PTCL-not otherwise specified (PTCL-NOS). Herein, we summarize the current genomic findings and their role in the molecular pathogenesis in different PTCL entities. Recent Findings: Gene expression profiling (GEP) studies have identified distinct molecular signatures for accurate diagnosis and elucidated oncogenic pathways enriched in major PTCL entities. Furthermore, genomic characterization has identified recurrent somatic mutations and potential therapeutic targets. Further efforts are underway to develop genetically faithful murine models. Summary: GEP studies have identified molecular subgroups of PTCL, characterized by distinct genetic and epigenetic alterations. Understanding the molecular mechanisms of T cell lymphomagenesis using in vivo model will help to reveal novel therapeutic targets.

AB - Purpose of Review: Peripheral T cell lymphoma (PTCL) is a heterogeneous group of lymphoproliferative neoplasms, with at least 29 distinct entities described in current WHO classification. Using present diagnostic approaches, more than a third of PTCL cases cannot be classified, hence designated as PTCL-not otherwise specified (PTCL-NOS). Herein, we summarize the current genomic findings and their role in the molecular pathogenesis in different PTCL entities. Recent Findings: Gene expression profiling (GEP) studies have identified distinct molecular signatures for accurate diagnosis and elucidated oncogenic pathways enriched in major PTCL entities. Furthermore, genomic characterization has identified recurrent somatic mutations and potential therapeutic targets. Further efforts are underway to develop genetically faithful murine models. Summary: GEP studies have identified molecular subgroups of PTCL, characterized by distinct genetic and epigenetic alterations. Understanding the molecular mechanisms of T cell lymphomagenesis using in vivo model will help to reveal novel therapeutic targets.

KW - Anaplastic large cell lymphoma

KW - Angioimmunoblastic T cell lymphoma

KW - Gene expression profiling

KW - Molecular signature

KW - Peripheral T cell lymphoma-not otherwise specified

KW - PTCL

UR - http://www.scopus.com/inward/record.url?scp=85049063898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049063898&partnerID=8YFLogxK

U2 - 10.1007/s11899-018-0460-z

DO - 10.1007/s11899-018-0460-z

M3 - Article

SP - 1

EP - 11

JO - Current Hematologic Malignancy Reports

JF - Current Hematologic Malignancy Reports

SN - 1558-8211

ER -